Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-05-27 Sale |
2025-05-29 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
2,558 | $10.23 | $26,179 | 2,806,084 (Indirect) |
View |
2025-05-22 Sale |
2025-05-27 4:02 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
2,182 | $10.91 | $23,804 | 2,808,642 (Indirect) |
View |
2025-05-20 Sale |
2025-05-22 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.04 | $44,160 | 2,810,824 (Indirect) |
View |
2025-05-16 Sale |
2025-05-20 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.21 | $44,840 | 2,814,824 (Indirect) |
View |
2025-05-14 Sale |
2025-05-16 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
2,020 | $10.69 | $21,586 | 2,818,824 (Indirect) |
View |
2025-05-12 Sale |
2025-05-14 4:04 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.96 | $43,860 | 2,820,844 (Indirect) |
View |
2025-03-21 Sale |
2025-03-25 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
174 | $10 | $1,740 | 2,824,844 (Indirect) |
View |
2025-03-19 Sale |
2025-03-21 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.11 | $40,440 | 2,825,018 (Indirect) |
View |
2025-03-17 Sale |
2025-03-19 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
2,242 | $11.89 | $26,658 | 2,829,018 (Indirect) |
View |
2025-03-13 Sale |
2025-03-17 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.05 | $48,220 | 2,831,260 (Indirect) |
View |
2025-03-11 Sale |
2025-03-13 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.57 | $46,280 | 2,835,260 (Indirect) |
View |
2025-03-07 Sale |
2025-03-11 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.19 | $40,776 | 2,839,260 (Indirect) |
View |
2025-03-05 Sale |
2025-03-07 4:02 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.89 | $43,560 | 2,843,260 (Indirect) |
View |
2025-03-03 Sale |
2025-03-05 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.04 | $44,180 | 2,847,260 (Indirect) |
View |
2025-02-27 Sale |
2025-03-03 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.37 | $45,480 | 2,851,260 (Indirect) |
View |
2025-02-25 Sale |
2025-02-27 4:02 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.5 | $46,000 | 2,855,260 (Indirect) |
View |
2025-02-21 Sale |
2025-02-25 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.3 | $45,190 | 2,859,260 (Indirect) |
View |
2025-02-19 Sale |
2025-02-21 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.35 | $49,380 | 2,863,260 (Indirect) |
View |
2025-02-14 Sale |
2025-02-19 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.21 | $48,860 | 2,867,260 (Indirect) |
View |
2025-02-12 Sale |
2025-02-14 4:00 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.59 | $46,360 | 2,871,260 (Indirect) |
View |
2025-02-10 Sale |
2025-02-12 8:45 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
3,878 | $11.72 | $45,435 | 2,875,260 (Indirect) |
View |
2025-02-06 Sale |
2025-02-11 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.51 | $50,020 | 2,879,158 (Indirect) |
View |
2025-02-04 Sale |
2025-02-06 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.01 | $48,029 | 2,883,138 (Indirect) |
View |
2025-01-31 Sale |
2025-02-04 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.49 | $45,960 | 2,887,138 (Indirect) |
View |
2025-01-29 Sale |
2025-01-31 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.4 | $45,600 | 2,891,138 (Indirect) |
View |
2025-01-27 Sale |
2025-01-29 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.35 | $45,380 | 2,895,138 (Indirect) |
View |
2025-01-23 Sale |
2025-01-27 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.69 | $42,760 | 2,899,138 (Indirect) |
View |
2025-01-21 Sale |
2025-01-24 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.74 | $42,960 | 2,903,138 (Indirect) |
View |
2025-01-16 Sale |
2025-01-21 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.71 | $42,860 | 2,907,138 (Indirect) |
View |
2025-01-14 Sale |
2025-01-16 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.62 | $42,480 | 2,911,138 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-06-04 Option Award |
2025-06-06 4:22 pm |
N/A 2035-06-04 |
GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director |
26,000 | $0 | 26,000 (Direct) |
View |
2025-06-04 Option Award |
2025-06-06 4:22 pm |
N/A 2035-06-04 |
GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director |
26,000 | $0 | 26,000 (Direct) |
View |
2025-06-04 Option Award |
2025-06-06 4:22 pm |
N/A 2035-06-04 |
GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director |
26,000 | $0 | 26,000 (Direct) |
View |
2025-06-04 Option Award |
2025-06-06 4:22 pm |
N/A 2035-06-04 |
GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director |
26,000 | $0 | 26,000 (Direct) |
View |
2025-06-04 Option Award |
2025-06-06 4:22 pm |
N/A 2035-06-04 |
GYRE THERAPEUTICS INC. | GYRE | Carmichael Gordon Director |
26,000 | $0 | 26,000 (Direct) |
View |
2025-05-27 Option Award |
2025-05-28 6:13 pm |
N/A 2035-05-27 |
GYRE THERAPEUTICS INC. | GYRE | Zhang Ping Director |
250,000 | $0 | 250,000 (Direct) |
View |
2025-04-01 Exercise |
2025-05-14 8:21 pm |
N/A 2030-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer |
50,000 | $0 | 1,665,115 (Direct) |
View |
2025-04-01 Exercise |
2025-05-14 8:21 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer |
50,000 | $0.75 | 1,665,115 (Direct) |
View |
2025-03-24 Exercise |
2025-04-25 4:01 pm |
N/A 2030-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer |
650,000 | $0 | 4,195,345 (Direct) |
View |
2025-03-24 Exercise |
2025-04-25 4:01 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer |
650,000 | $0.75 | 4,195,345 (Direct) |
View |
2025-04-16 Exercise |
2025-04-18 5:27 pm |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director |
15,000 | $0 | 314,652 (Direct) |
View |
2025-04-16 Exercise |
2025-04-18 5:27 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director |
15,000 | $6.93 | 314,652 (Direct) |
View |
2025-03-07 Option Award |
2025-03-11 8:00 pm |
N/A 2035-03-07 |
GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer |
300,000 | $0 | 300,000 (Direct) |
View |